Diabetes mellitus in pancreatic cancer: is it a causal relationship?

American Journal of Surgery

Volumn 194, Issue 4 SUPPL., 2007, Pages

  Katsumichi, Iki ^a   Pour, Parviz M ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Diabetes; Islet amyloid polypeptides; Islet cells; Morphometry; Pancreas cancer

Indexed keywords

AMYLOID PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AMYLOID; BLOOD GLUCOSE; CAUSALITY; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PANCREATIC POLYPEPTIDE-SECRETING CELLS;

EID: 34548848287     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.05.024     Document Type: Article

References (25)

1. Chow W.H., Gridley G., Nyren O., et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 87 (1995) 930-931
2. Cuzick J., and Babiker A.G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 43 (1989) 415-421
3. Ragozzino M., Melton III L.J., Chu C.P., et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35 (1982) 13-19
4. Silverman D.T., Swanson C.A., Gridley G., et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 90 (1998) 1710-1719
5. Cetin M., Colak R., Bayram F., et al. High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey. Diabetes Res Clin Pract 58 (2002) 97-100
6. Karmody A.J., and Kyle J. The association between carcinoma of the pancreas and diabetes mellitus. Br J Surg 56 (1969) 362-364
7. Permert J., Adrian T.E., Jacobsson P., et al. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?. Am J Surg 165 (1993) 61-66 discussion 66-7
8. Permert J., Ihse I., Jorfeldt L., et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80 (1993) 1047-1050
9. Permert J., Ihse I., Jorfeldt L., et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159 (1993) 101-107
10. Permert J., Larsson J., Westermark G.T., et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 330 (1994) 313-318
11. Iki K., Pour P.M., Parviz M., et al. Distribution of panvcreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases. J Histochem Cytochem (2006)
12. Pour P.M., Kazakoff K., and Dulaney K. A new multilabeling technique for simultaneous demonstration of different islet cells in permanent slides. Int J Pancreatol 13 (1993) 1349-1353
13. Gullo L. Diabetes and the risk of pancreatic cancer. Ann Oncol 10 suppl 4 (1999) 79-81
14. Gullo L., Pezzilli R., and Morselli-Labate A.M. Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. N Engl J Med 331 (1994) 81-84
15. Verchere C.B., D'Alessio D.A., Prigeon R.L., et al. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes 49 (2000) 1477-1484
16. Brand R.E., Ding X.Z., Young C.M., et al. The specificity of amylin for the diagnosis of pancreatic adenocarcinoma. Int J Gastrointest Cancer 31 (2002) 123-128
17. Chari S.T., Klee G.G., Miller L.J., et al. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121 (2001) 640-645
18. Basso D., Greco E., Fogar P., et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?. Clin Chim Acta (2006)
19. Iacobuzio-Donahue C.A., Ashfaq R., Maitra A., et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 63 (2003) 8614-8622
20. Missiaglia E., Blaveri E., Terris B., et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112 (2004) 100-112
21. Rosty C., Ueki T., Argani P., et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 160 (2002) 45-50
22. Shen J., Person M.D., Zhu J., et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64 (2004) 9018-9026
23. Bouma G., Coppens J.M., Lam-Tse W.K., et al. An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes. Clin Exp Immunol 141 (2005) 509-517
24. Joseph J.W., Koshkin V., Saleh M.C., et al. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem 279 (2004) 51049-51056
25. Ibrahimi A., Bonen A., Blinn W.D., et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274 (1999) 26761-26766